Odyssey Health (ODYY) Assets Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Odyssey Health | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 170.29% |
| Oct 31, 2025 | -57.89% |
| Jul 31, 2025 | -91.52% |
| Apr 30, 2025 | -98.79% |
| Jan 31, 2025 | -98.10% |
| Oct 31, 2024 | -44.28% |
| Jul 31, 2024 | 28.60% |
| Apr 30, 2024 | 3,014.39% |
| Jan 31, 2024 | 2,931.61% |
| Oct 31, 2023 | -29.47% |
| Jul 31, 2023 | -19.99% |
| Apr 30, 2023 | -29.59% |
| Jan 31, 2023 | 38.67% |
| Oct 31, 2022 | -6.88% |
| Jul 31, 2022 | -6.69% |
| Apr 30, 2022 | -57.41% |
| Jan 31, 2022 | 140.86% |
| Oct 31, 2021 | 133.78% |
| Jul 31, 2021 | 478.24% |
| Apr 30, 2021 | 420.79% |
| Jan 31, 2021 | -55.11% |
| Oct 31, 2020 | 18.61% |
| Jul 31, 2020 | -80.32% |
| Apr 30, 2020 | 995.42% |
| Jan 31, 2020 | 1,278.69% |
| Oct 31, 2019 | 1,221.18% |
| Jul 31, 2019 | 1,853.62% |
| Apr 30, 2019 | -28.92% |
| Jan 31, 2019 | 715.94% |
| Oct 31, 2018 | -85.71% |
| Jul 31, 2018 | -82.76% |
| Apr 30, 2018 | -58.78% |
| Jan 31, 2018 | -96.33% |
| Oct 31, 2017 | 211.14% |
| Jul 31, 2017 | 132.81% |
| Apr 30, 2017 | 2.40% |
| Jan 31, 2017 | 4,717.70% |
| Oct 31, 2016 | 887.33% |
| Jul 31, 2016 | 1,178.60% |
| Jul 31, 2015 | -97.91% |